Limited Period Offer: Get up to 10% off + extra 15% off on medicines & more offers. Explore
(0) Write a review
In stock

Mounjaro® Weight Loss Injectable Pen

Preisspanne: €148.00 bis €298.00

150 people are viewing this right now
  • Clinically proven to help you lose 22.5% of your body weight on average
  • Reduces your appetiteregulates blood sugar and helps you feel fuller for longer
  • Weight management plans may be suitable if you have a BMI of 25 or more
  • Safe and effective for long-term weight loss and weight maintenance
  • Delivered in plain, discreet packaging to protect your privacy
Buy now
  • Free Shipping Icon SVG Vector & PNG Free Download | UXWingFree Shipping & Returns on this item
  • Delivery within 3-5 working days
  • Money Back Guarantee

Description

Mounjaro: The Most Effective Doctor-Prescribed Weight Loss Treatment in Europe

Mounjaro (active ingredient: tirzepatide) is a once-weekly injectable medication that produces the highest average weight loss of any prescription treatment currently licensed in Europe. Clinical trials published in The New England Journal of Medicine show an average weight reduction of 20.9% over 72 weeks at the maximum 15 mg maintenance dose — significantly higher than older GLP-1 medications. At EU Slim Store, we make Mounjaro accessible through a free online consultation with a Dutch BIG-registered doctor and supply from a fully IGJ-registered pharmacy in the Netherlands.

How Mounjaro Works — A Dual-Hormone Breakthrough

Mounjaro is the first weight loss medication to mimic two natural gut hormones simultaneously: GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Older medications like Wegovy and Ozempic mimic only GLP-1. The dual action is why Mounjaro is so effective.

Once injected weekly, tirzepatide:

  • Slows the rate at which food empties from your stomach, keeping you fuller for longer
  • Reduces appetite signals in the brain’s hunger and reward centres
  • Improves how your body responds to insulin, stabilising blood sugar levels
  • Reduces cravings — particularly for high-fat and high-sugar foods

Most patients notice a dramatic reduction in hunger within the first one to two weeks. Visible weight loss typically begins around weeks three to four, with significant changes (10%+ of starting body weight) achieved over four to six months at appropriate maintenance doses.

Who Is Mounjaro For?

Mounjaro is appropriate for adults seeking sustained weight loss under medical supervision. In line with EU clinical guidelines, our doctors will typically prescribe Mounjaro when:

  • Your BMI is 30 or above, or
  • Your BMI is 27 or above and you have at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea, cardiovascular disease, or non-alcoholic fatty liver disease

Final eligibility is always determined by your reviewing doctor based on a full medical history, not just BMI alone.

Mounjaro Dosing Schedule — Gradual Titration for Best Tolerance

All patients begin Mounjaro at the starter dose of 2.5 mg once weekly for the first four weeks. This intentionally low starting dose lets your body adjust and minimises side effects. After the initial period, your doctor will guide a gradual increase every four weeks based on how you tolerate the medication and your response:

  • Weeks 1–4: 2.5 mg (starter dose, not a therapeutic dose)
  • Weeks 5–8: 5 mg
  • Weeks 9–12: 7.5 mg
  • Weeks 13–16: 10 mg
  • Weeks 17–20: 12.5 mg
  • Week 21+: 15 mg (maximum maintenance dose)

Most patients reach a comfortable maintenance dose between 5 mg and 15 mg. Your reviewing doctor will help determine the right long-term dose for you based on weight loss progress and side effect tolerance.

How to Inject Mounjaro

Mounjaro comes as a pre-filled single-use injector pen with a very thin needle that’s barely felt. Each pen contains one weekly dose. You inject under the skin (subcutaneously) in your abdomen, thigh, or upper arm — the same day of the week, with or without food. Switch injection sites each week to avoid skin irritation.

A nurse provides a video walkthrough with your first delivery, and you can message your prescribing doctor anytime with questions through our secure patient portal.

Common and Serious Side Effects

The most common side effects are gastrointestinal and typically mild:

  • Nausea (~25% of patients, usually in first 2–4 weeks)
  • Diarrhoea or constipation
  • Reduced appetite
  • Fatigue or mild headache
  • Mild injection site reactions

Most side effects fade within two to four weeks as your body adjusts to each new dose. Drinking plenty of water, eating smaller protein-rich meals, and avoiding fatty or spicy food helps significantly.

Serious side effects are rare but require immediate medical attention. Contact your doctor or seek urgent care if you experience severe abdominal pain (possible pancreatitis), signs of gallbladder issues, persistent vomiting, vision changes, or signs of an allergic reaction such as facial swelling or difficulty breathing. Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Mounjaro vs. Other GLP-1 Medications

Treatment Active ingredient Average weight loss Frequency
Mounjaro Tirzepatide 20.9% Weekly
Wegovy Semaglutide 14.9% Weekly
Ozempic Semaglutide 10–15% Weekly
Saxenda Liraglutide 8–12% Daily

Mounjaro produces the strongest weight loss results because of its dual GLP-1 + GIP mechanism. Your doctor will discuss whether Mounjaro or an alternative is right for you based on your medical history, response to previous treatments, and goals.

How to Buy Mounjaro Online from EU Slim Store

The process is fully online, secure, and takes only minutes:

  1. Complete the free consultation form — five minutes of medical questions (BMI, history, current medications, eligibility)
  2. A Dutch BIG-registered doctor reviews your case within 24 hours
  3. If appropriate, your doctor issues a prescription and answers any questions you have
  4. Our IGJ-registered Dutch pharmacy dispenses your treatment in original manufacturer packaging
  5. PostNL delivery in 3–5 working days in temperature-controlled, discreet packaging

No need to visit a clinic. No waiting rooms. No paperwork. Just a confidential medical consultation with a licensed doctor and pharmacy-grade treatment delivered to your door.

Storage and Handling

Store unopened Mounjaro pens in the refrigerator at 2–8 °C in the original packaging, away from light. Do not freeze. Once in use, a pen can be kept at room temperature (below 30 °C) for up to 21 days. Always check the liquid before injecting — it should be clear and colourless. Do not use if cloudy or containing particles.

Pricing and What’s Included

Our Mounjaro pricing is transparent and all-inclusive: medication, doctor consultation, pharmacy dispensing, and PostNL delivery. No hidden fees. No surprise charges. Monthly cost starts at €148 for the starter dose, scaling with your maintenance dose level. Reorder when ready — your doctor’s ongoing monitoring is included.

Ready to Start?

Take the free five-minute eligibility consultation now. A Dutch BIG-registered doctor will review your case and respond within 24 hours. You’ll only pay if your doctor approves treatment — there’s no obligation to proceed.

Zusätzliche Informationen

Dosage

2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg

Mounjaro FAQs

Mounjaro (tirzepatide) is a once-weekly injection that mimics two natural gut hormones — GLP-1 and GIP — to regulate appetite, slow stomach emptying, and improve insulin response. It produces the highest average weight loss of any treatment licensed in Europe, with clinical trials showing approximately 22.5% weight loss over 72 weeks at the maximum 15 mg dose. The dual-hormone mechanism makes Mounjaro more effective than older GLP-1 medications like Wegovy or Ozempic that target only one hormone.

In line with EU clinical guidance, Mounjaro is appropriate for adults with a BMI of 30 or above, or a BMI of 27 or above combined with at least one weight-related condition such as type 2 diabetes, high blood pressure, sleep apnoea, or cardiovascular disease. Final eligibility is always confirmed by a licensed doctor based on your complete medical history and current medications during the free online consultation.

Published clinical trials show an average weight loss of approximately 22.5% over 72 weeks at the maximum 15 mg maintenance dose — the highest of any approved weight loss medication. Individual results vary based on starting weight, dose, adherence to lifestyle changes, and how your body responds. Most patients see noticeable changes within the first 4–8 weeks, with significant weight loss (10%+ of starting body weight) achieved over 4–6 months.

Mounjaro comes as a pre-filled single-use injector pen with a very thin needle. You inject it under the skin (subcutaneously) in your abdomen, thigh, or upper arm once a week on the same day. Each pen contains one weekly dose. Our nurse provides a video walkthrough with your first delivery, and you can message your doctor anytime through our secure patient portal.

All patients start at 2.5 mg once weekly for the first four weeks. This intentionally low starting dose lets your body adjust and minimises gastrointestinal side effects. Your doctor will guide a gradual increase every 4 weeks: 5 mg, 7.5 mg, 10 mg, 12.5 mg, up to a maximum maintenance dose of 15 mg. Most patients settle between 5 mg and 15 mg depending on tolerance and response.

The most common side effects are nausea (around 25% of patients), diarrhoea, vomiting, constipation, and decreased appetite. Most are mild and resolve within 2–4 weeks as your body adjusts to each dose. Severe side effects are rare but include pancreatitis, gallbladder issues, and serious allergic reactions. Contact your doctor or seek urgent care if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction.

Wegovy and Ozempic both contain semaglutide, which mimics one hormone (GLP-1). Mounjaro contains tirzepatide, which mimics two hormones (GLP-1 and GIP). The dual mechanism is why Mounjaro produces higher average weight loss in clinical trials (around 22.5% vs around 14.9% for Wegovy). Whether Mounjaro is the right choice depends on your medical history, side effect tolerance, and treatment goals.

Most patients notice reduced appetite and food cravings within the first 1–2 weeks. Visible weight loss typically begins around weeks 3–4. Significant weight loss (10% or more of starting weight) generally takes 4–6 months at appropriate maintenance doses. Tracking your weight weekly and keeping a simple food journal helps you and your doctor see the trend clearly.

Moderate alcohol is not strictly forbidden, but limiting intake is recommended, especially in the first weeks of treatment. Alcohol can worsen nausea, increase the risk of low blood sugar (particularly if you have type 2 diabetes), and contribute calories that work against your weight loss goals. We recommend avoiding alcohol during dose increases and discussing your individual situation with your reviewing doctor.

A balanced diet supports the medication's effect. Prioritise lean protein (around 1.2–1.6 g per kg of body weight daily), vegetables, and adequate hydration (around 2 L per day). Eat smaller, more frequent meals to manage nausea and the feeling of fullness. Avoid very fatty, greasy, or heavily spiced meals, which can worsen nausea — especially during the first weeks and after each dose increase.

If you miss your weekly dose, take it as soon as you remember — as long as it's within 4 days (96 hours) of your scheduled day. If more than 4 days have passed, skip the missed dose and take your next dose on your regular weekly day. Never take two doses to catch up. If you miss multiple weeks, message your doctor before resuming.

Store unused Mounjaro pens in the refrigerator at 2–8 °C, in the original packaging to protect from light. Do not freeze. Once in use, a pen can be kept at room temperature (below 30 °C) for up to 21 days. Always check the liquid before injecting — it should be clear and colourless. Don't use the pen if it looks cloudy or contains particles.

Mounjaro is not recommended during pregnancy, while trying to conceive, or while breastfeeding. We advise stopping Mounjaro at least 2 months before trying to conceive. If you use hormonal birth control, note that Mounjaro's slowed stomach emptying can affect absorption of oral contraceptives — discuss alternative or backup contraception with your doctor for at least 4 weeks after starting and after each dose increase.

Without continued treatment, most patients regain a significant portion of the weight they lost within 12 months. Clinical studies show roughly two-thirds of lost weight typically returns within a year of stopping. Many patients continue Mounjaro long-term at a maintenance dose, while others transition to lifestyle-only management with continued doctor support.

In the Netherlands, basic health insurance covers tirzepatide only in specific cases — primarily for confirmed type 2 diabetes. Most patients using Mounjaro for weight management pay privately. Some supplementary insurance policies may reimburse part of the cost — check with your zorgverzekeraar. Our pricing is all-inclusive: medication, doctor consultation, pharmacy dispensing, and PostNL delivery, with no hidden fees.

Reviews

Be the first to review “Mounjaro® Weight Loss Injectable Pen”

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert

There are no reviews yet.

Search

Back to Top

Shipping Address

Product has been added to your cart
Compare (0)